Obstetric and newborn infant outcomes in human immunodeficiency virus-infected women who receive highly active antiretroviral therapy

American Journal of Obstetrics and Gynecology

Volumn 201, Issue 3, 2009, Pages 315.e1-315.e5

  Haeri, Sina ^a   Shauer, Marla ^b   Dale, Monica ^b   Leslie, Jennie ^b   Baker, Arthur M ^a   Saddlemire, Stephanie ^b   Boggess, Kim ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

highly active antiretroviral therapy; human immunodeficiency virus; low birthweight; pregnancy; preterm birth

Indexed keywords

COCAINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ADULT; AFRICAN AMERICAN; ARTICLE; CHORIOAMNIONITIS; COCAINE DEPENDENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FETUS OUTCOME; GASTROESOPHAGEAL REFLUX; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOVOLEMIA; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; NEWBORN SEPSIS; PNEUMONIA; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURITY; PRIORITY JOURNAL; RISK FACTOR; SMALL FOR DATE INFANT; SMOKING; SOLUTIO PLACENTAE;

EID: 69349103203     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2009.06.017     Document Type: Article

References (18)

1. Mofenson L.M. Technical report: perinatal human immunodeficiency virus testing and prevention of transmission: Committee on Pediatric AIDS. Pediatrics 106 (2000) E88
2. Centers for Disease Control and Prevention (CDC). Achievements in public health: reduction in perinatal transmission of HIV infection-United States, 1985-2005. MMWR Morb Mortal Wkly Rep 55 (2006) 592-597
3. Mocroft A., Vella S., Benfield T.L., et al. Changing patterns of mortality across Europe in patients infected with HIV. Lancet 352 (1998) 1725-1730
4. Perinatal HIV Guidelines Working Group. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. http://aidsinfo.nih.gov/ContentFiles Accessed Feb. 5, 2009
5. Wimalasundera R.C., Larbalestier N., Smith J.H., et al. Pre-eclampsia, antiretroviral therapy, and immune reconstitution. Lancet 360 (2002) 1152-1154
6. Suy A., Martínez E., Coll O., et al. Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy. AIDS 20 (2006) 59-66
7. Dube M.P., and Sattler F.R. Metabolic complications of antiretroviral therapies. AIDS Clin Care 10 (1998) 41-44
8. Brocklehurst P., and French R. The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis. BJOG 105 (1998) 836-848
9. Leroy V., Ladner J., Nyiraziraje M., et al. Effect of HIV-1 infection on pregnancy outcome in women in Kigali, Rwanda, 1992-1994. AIDS 12 (1998) 643-650
10. Ross M.G., and Beall M.H. Adult sequelae of intrauterine growth restriction. Semin Perinatol 32 (2008) 213-218
11. Brocklehurst P., and French R. The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis. BJOG 105 (1998) 836-848
12. Martin R., Boyer P., Hammill H., et al. Incidence of premature birth and neonatal respiratory disease in infants of HIV-positive mothers: the Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted Human Immunodeficiency Virus Infection study group. J Pediatr 131 (1997) 851-856
13. Lorenzi P., Spicher V.M., Laubereau B., et al. Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects: Swiss HIV Cohort study, the Swiss Collaborative HIV and Pregnancy study, and the Swiss Neonatal HIV study. AIDS 12 (1998) F241-F247
14. European Collaborative Study. Combination antiretroviral therapy and duration of pregnancy. AIDS 14 (2000) 2913-2920
15. Tuomala R.E., Shapiro D.E., Mofenson L.M., et al. Antiretroviral therapy during pregnancy and the risk of an adverse outcome. N Engl J Med 346 (2002) 1863-1870
16. Tuomala R.E., Watts D.H., Li D., et al. Improved obstetric outcomes and few maternal toxicities are associated with antiretroviral therapy, including highly active antiretroviral therapy during pregnancy. J Acquir Immune Defic Syndr 38 (2005) 449-473
17. Tuomala R.E., and Yawetz S. Protease inhibitor use during pregnancy: is there an obstetrical risk?. J Infect Dis 193 (2006) 1191-1194
18. Kourtis A.P., Schmid C.H., Jamieson D.J., and Lau J. Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis. AIDS 21 (2007) 607-615